| Immune-glutamatergic dysfunction as a central mechanism of the autism spectrum disorders RL Blaylock, A Strunecka Current medicinal chemistry 16 (2), 157-170, 2009 | 173 | 2009 |
| Pharmacological and toxicological effects of aluminofluoride complexes A Strunecka, J Patocka Fluoride 32 (4), 230-242, 1999 | 123 | 1999 |
| Fluorine in medicine A Strunecká, J Patočka, P Connett J Appl Biomed 2, 141-150, 2004 | 122 | 2004 |
| Fluoride interactions: from molecules to disease A Strunecka, J Patocka, RL Blaylock, NJ Chinoy Current Signal Transduction Therapy 2 (3), 190-213, 2007 | 96 | 2007 |
| 2002 Fluoride Abstracts. Part 1. A Strunecka, O Strunecky, J Patocka Physiol Res 51 (6), 557-564, 2002 | 80 | 2002 |
| Mechanisms of fluoride toxicity: from enzymes to underlying integrative networks A Strunecka, O Strunecky Applied Sciences 10 (20), 7100, 2020 | 61 | 2020 |
| Doba jedová A Strunecká, J Patočka Triton, 2011 | 52 | 2011 |
| Phospholipid and calcium alterations in platelets of schizophrenic patients D Řípová, A Strunecka, V Němcová, I Farska Physiol Res 46, 59-68, 1997 | 51 | 1997 |
| Chronic fluoride exposure and the risk of autism spectrum disorder A Strunecka, O Strunecky International journal of environmental research and public health 16 (18), 3431, 2019 | 42 | 2019 |
| Role of oxytocin/oxytocin receptor system in regulation of cell growth and neoplastic processes A Strunecka, S Hynie, V Klenerova Folia biologica 55 (5), 159, 2009 | 41 | 2009 |
| Immunoexcitotoxicity as the central mechanism of etiopathology and treatment of autism spectrum disorders: A possible role of fluoride and aluminum A Strunecka, RL Blaylock, J Patocka, O Strunecky Surgical neurology international 9, 2018 | 40 | 2018 |
| Expectations of biologically active compounds of the genus Magnolia in biomedicine J Patočka, J Jakl, A Strunecká J. Appl. Biomed 4 (4), 171-178, 2006 | 32 | 2006 |
| Aluminofluoride complexes in the etiology of Alzheimer’s disease A Strunecká, J Patočka Group 13 Chemistry II: Biological Aspects of Aluminum, 139-180, 2002 | 31 | 2002 |
| Transbilayer redistribution of phosphatidylserine in erythrocytes of a patient with autoerythrocyte sensitization syndrome (psychogenic purpura). A Strunecka, L Krpejsova, J Palecek, J Macha, M Maturova, L Rosa, ... Folia Haematologica (Leipzig, Germany: 1928) 117 (6), 829-841, 1990 | 30 | 1990 |
| What can the investigation of phosphoinositide signaling system in platelets of schizophrenic patients tell us? A Strunecka, D Řı́pov Prostaglandins, leukotrienes and essential fatty acids 61 (1), 1-5, 1999 | 26 | 1999 |
| Cytosolic calcium alterations in platelets of patients with early stages of Alzheimer’s disease D Řı́pová, V Platilova, A Strunecka, R Jirak, C Höschl Neurobiology of aging 21 (5), 729-734, 2000 | 23 | 2000 |
| The effect of inositol 1, 4, 5-trisphosphate and inositol 1, 4, 5-trisphosphorothioate on calcium release and membrane skeleton organization in the human red blood cell. A Strunecka, NI El Desouki, J Palecek, E Kmonickova, L Krpejsova, ... Receptor 1 (3), 141-154, 1991 | 17 | 1991 |
| Aluminofluoride complexes: a useful tool in laboratory investigations, but a hidden danger for living organisms? A Strunecka, J Patocka | 16 | 2002 |
| Reassessment of the role of aluminum in the development of Alzheimer's disease A Strunecka, J Patocka Cesk Fysiol 48 (1), 9-15, 1999 | 16 | 1999 |
| Fluoride, aluminum, and aluminofluoride complexes in pathogenesis of the autism spectrum disorders: A possible role of immunoexcitotoxicity A Strunecka, RL Blaylock, O Strunecky journal of applied biomedicine 14 (3), 171-176, 2016 | 15 | 2016 |
